RCC Laboratories, a Hyderabad-based contract research organisation providing pre-clinical, safety toxicology and chemical testing globally, today entered into a partnership with Austria-based ViruSure GmbH to market the latter’s services in India.
ViruSure, a privately-owned biotech company, specialises in the virus and prion safety testing of biopharmaceutical products, and cell banking and characterisation services.
“The partnership is a natural fit, since both RCC and ViruSure will help Indian companies elevate their quality standards through their combined service offerings. We look forward to offer our experience to assist Indian biopharmaceutical companies in reaching their goals for pathogen safety testing,” Andy Bailey, chief and co-founder of ViruSure, said in a release on Tuesday.